Clinical Trial Update: Daily Topical Rapamycin for Vitiligo [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating daily topical rapamycin for vitiligo; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Rapamycin (topical) (sirolimus)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Vitiligo | Phase 2 | Status: ACTIVE_NOT_RECRUITING